Elevation Oncology Inc (NASDAQ: ELEV) is -48.44% lower on its value in year-to-date trading and has touched a low of $0.24 and a high of $5.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELEV stock was last observed hovering at around $0.30 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.29, the stock is -38.81% and -50.41% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.79 million and changing -3.33% at the moment leaves the stock -73.25% off its SMA200. ELEV registered -93.32% loss for a year compared to 6-month gain of -51.63%. The firm has a 50-day simple moving average (SMA 50) of $0.58506 and a 200-day simple moving average (SMA200) of $1.084655.
The stock witnessed a -52.24% loss in the last 1 month and extending the period to 3 months gives it a -53.58%, and is -44.84% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.95% over the week and 11.59% over the month.
Elevation Oncology Inc (ELEV) has around 34 employees, a market worth around $17.18M and $0.00M in sales. Distance from 52-week low is 20.37% and -95.02% from its 52-week high. The company has generated returns on investments over the last 12 months (-48.80%).
The EPS is expected to grow by 16.83% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Elevation Oncology Inc (ELEV) Top Institutional Holders
94.0 institutions hold shares in Elevation Oncology Inc (ELEV), with institutional investors hold 67.99% of the company’s shares. The shares outstanding are 59.13M, and float is at 52.06M with Short Float at 16.44%. Institutions hold 67.77% of the Float.
The top institutional shareholder in the company is LOGOS GLOBAL MANAGEMENT LP with over 3.85 million shares valued at $10.39 million. The investor’s holdings represent 6.5234% of the ELEV Shares outstanding. As of 2024-06-30, the second largest holder is FARALLON CAPITAL MANAGEMENT LLC with 3.6 million shares valued at $$9.72 million to account for 6.0971 of the shares outstanding. The other top investors are TANG CAPITAL MANAGEMENT LLC which holds 3.06 million shares representing 5.1848% and valued at over $8.26 million, while FRAZIER LIFE SCIENCES MANAGEMENT, L.P. holds 5.013 of the shares totaling 2.96 million with a market value of $7.99 million.
Elevation Oncology Inc (ELEV) Insider Activity
#####
